LifeTech Scientific's share capital stable despite option scheme lapses

LifeTech Scientific Corporation reported no changes to its authorized or registered share capital for the month ended September 30, 2025. It maintained its capital at $50,000, derived from 40,000,000,000 ordinary shares with a par value of $0.00000125 each. The total number of issued shares also remained constant at 4,631,712,400, with no new shares issued or treasury shares transferred during the month.

Movement within its share option schemes included 147,500 lapsed options from its second scheme, bringing outstanding options in that scheme to 284,935,000. No new shares were issued from any option scheme during the period, resulting in zero funds raised from the exercise of options.

The company's first share option scheme maintained 25,590,000 outstanding options. The total number of shares that may be issued upon exercise of all options to be granted under the second scheme, as of the close of the month, stands at 151,379,240.